openPR Logo
Press release

Antiobesity Market Report 2024: Strategies And Recent Developments | F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc

Antiobesity  Market Trends

Antiobesity Market Trends

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Antiobesity Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The antiobesity market size has grown rapidly in recent years. It will grow from $3.38 billion in 2023 to $3.76 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing obesity prevalence, awareness and education, lifestyle changes, government initiatives.

The antiobesity market size is expected to see rapid growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to market expansion, globalization. Major trends in the forecast period include research and development, patient-centric approaches, insurance coverage, technological advancements, digital health and telemedicine, novel drug therapies, bariatric surgery advancements, otc (over-the-counter) solutions, behavioral interventions, nutritional and weight management apps.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

Market Segmentation:
The main classes of drugs in anti-obesity are peripherally acting anti-obesity drugs and centrally acting anti-obesity drugs. Antiobesity medications with a peripheral effect help people lose weight without influencing the brain or decreasing their appetite. It blocks pancreatic lipase and hinders fat breakdown in the gastrointestinal tract, lowering fat absorption through the intestine. The different types of drugs include prescription drugs (Rx), and OTC drugs and involve various medications such as monotherapies and polytherapy.

Major Driver - Rising Prevalence Rate Of Obesity In The Anti-Obesity Drugs Market
Obesity is a major public health concern globally. Globally, the prevalence rate of obesity is increasing every year. For instance, in May 2022, according to the World Obesity Atlas, a UK-based obesity organization, globally, it is estimated that more than 1 billion people will be suffering from obesity by 2030. This can be attributed to increased consumption of processed and unhealthy food, lack of physical activity, and lack of awareness of the risks of obesity. As a result, the demand for anti-obesity drugs is bound to increase in the future thus, driving the market growth.

Competitive Landscape:
Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report

Top Trend - Product Innovations In The Anti-Obesity Drug Market
Major companies operating in the anti-obesity drugs market are focusing on innovating new products, such as Mounjaro (tirzepatide), to provide reliable services to customers. Mounjaro (tirzepatide) is used as an anti-obesity drug for the treatment of adults with obesity or overweight with weight-related comorbidities. For instance, in October 2022, Eli Lilly and Company,a US-based pharmaceutical company, launched Mounjaro (tirzepatide), approved by the Food and Drug Administration (FDA), a US-based federal agency, as a fast track designation treatment. Mounjaro (tirzepatide) is an injectable form of anti-obesity drug used to help individuals struggling with obesity achieve their weight loss goals. This is used for adults with type 2 diabetes, along with diet and exercise, to improve blood sugar (glucose).

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Antiobesity Market Characteristics
3. Antiobesity Market Trends And Strategies
4. Antiobesity Market - Macro Economic Scenario
5. Antiobesity Market Size And Growth
…..
27. Antiobesity Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiobesity Market Report 2024: Strategies And Recent Developments | F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc here

News-ID: 3405770 • Views:

More Releases from The Business research company

Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancing Geophysical Surveys With Drones For Efficiency In Harsh Environments
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period? The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.

All 5 Releases


More Releases for Antiobesity

AntiObesity Drugs Market to Reach USD 100.97 Billion by 2030, Driven by GLP1 Inc …
Mordor Intelligence has published a new report on the AntiObesity Drugs Market, offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction Mordor Intelligence, in its latest antiobesity drugs market report, forecasts the market to reach from USD25.93billion in 2025 to USD100.97billion by 2030, advancing at a 31.24% CAGR. The anti-obesity drugs market [https://www.mordorintelligence.com/industry-reports/anti-obesity-drugs-market?utm_source=abnewswire] focuses on medications developed to aid in weight loss and manage obesity related conditions. Obesity is
Antiobesity Market Trends, Strategies, Size, Share And Analysis 2024-2033
"The Business Research Company recently released a comprehensive report on the Global Antiobesity Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of
Antiobesity Market Research In-Depth Analysis, Applications, Forecast To 2033
The new report published by The Business Research Company, titled Antiobesity Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the antiobesity market size has grown rapidly in recent years. It will grow from $3.38 billion in 2023 to $3.76
Antiobesity Market Potential Analysis, Key Drivers, Emerging Growth, Trends And …
The antiobesity market size has grown rapidly in recent years. It will grow from $3.38 billion in 2023 to $3.76 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing obesity prevalence, awareness and education, lifestyle changes, government initiatives. The antiobesity market size is expected to see rapid growth in the next few years. It will
Global Antiobesity Market 2024 - Industry Segments, Drivers, Trends, Forecast to …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033 The Business Research Company's Antiobesity Global Market Report 2024 identifies rising geriatric population as the major driver for the Antiobesity market's growth in the forecast period. The geriatric population refers to the segment of the elderly or older, typically aged 65 and older. Anti-obesity drugs are a
Antiobesity Market Explores Overall Study To Share, Demand, Growth And Predictio …
Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies! https://www.thebusinessresearchcompany.com/opportunities-and-strategies-reports The global antiobesity market report by the business research company the demand for anti-obesity drugs is bound to increase in the future to be a major growth driver for the antiobesity market. Obesity is a major public health concern globally. Globally, the prevalence rate of obesity is